THE PRIVATE CLINIC (TPC)
Acquired by
QUADRIVIO GROUP
THE PRIVATE CLINIC (TPC) acquired by QUADRIVIO GROUP
Target
THE PRIVATE CLINIC (TPC)
Acquirer
QUADRIVIO GROUP
Context
Quadrivio Group has acquired a majority stake in The Private Clinic from BlueGem Capital Partners to serve as a platform for its "Silver Economy" strategy. The industrial logic is anchored in the "healthy longevity" megatrend: as the population ages, demand for aesthetic and wellness treatments among the affluent over-50s is booming. The transaction was structured as a simultaneous "Buy-and-Build" play, as TPC acquired four smaller clinics specializing in cosmetic medicine at closing to immediately scale its footprint. Quadrivio aims to use TPC to consolidate the highly fragmented aesthetic market in the UK and plans to export this business model to Italy and broader Europe, where similar consolidation opportunities exist.
This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded over 40 years ago and headquartered on London's Harley Street, The Private Clinic (TPC) is a premium provider of medical cosmetic treatments. It operates a network of seven clinics and one hospital (The Fitzroy Hospital) across the UK. The group offers a comprehensive range of procedures, ranging from plastic surgery and liposuction to non-invasive skin treatments, hair transplants, and varicose vein removal.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with THE PRIVATE CLINIC (TPC)
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.